A Phase I clinical trial of chimeric antigen receptor-modified T cells in patients with relapsed and refractory lymphoma.
暂无分享，去创建一个
Hongling Zhang | Yan-fang Liu | YOUHAI H. Chen | Ling Li | Zhaoming Li | K. Cui | Xiao-yan Feng | Mingzhi Zhang | Xudong Zhang | Xin Li | Lei Zhang | Zhenchang Sun | Hui Yu | Xiaolong Wu | Wang Ma | Feng Li | X. Wan | Youhai H. Chen | Zhen Zhang | Xinfeng Chen | Zhi-yuan Zhou | Hong Li | Jianmin Huang | Ying Zeng | Yi Zhang | Y. Zeng | Feng Li | F. Li | Feng Li | F. Li | Feng Li | Mingzhi Zhang